Displaying 97 - 108 of 136
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View
Metabolism, Alcohol & Toxicity
6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View
Metabolism, Alcohol & Toxicity
6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View
Metabolism, Alcohol & Toxicity
6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View
Metabolism, Alcohol & Toxicity
6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View
Metabolism, Alcohol & Toxicity
6

Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021

View
Displaying 97 - 108 of 136